Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 87: 438-443, 1999;
8750-7587/99 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roum, J. H.
Right arrow Articles by Crystal, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roum, J. H.
Right arrow Articles by Crystal, R. G.
Vol. 87, Issue 1, 438-443, July 1999

Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis

James H. Roum1,2, Zea Borok1,4, Noel G. McElvaney1, George J. Grimes3, Allan D. Bokser3, Roland Buhl1, and Ronald G. Crystal1,5

1 Pulmonary Branch, National Heart, Lung, and Blood Institute, and 3 Pharmacy Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892; 2 Division of Pulmonary and Critical Care Medicine, University of California Irvine Medical Center, Orange 92868; 4 Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Southern California, Los Angeles, California 90033; and 5 Division of Pulmonary Critical Care Medicine, The New York Hospital-Cornell Medical Center, New York, New York 10021

Cystic fibrosis (CF) is characterized by accumulation of activated neutrophils and macrophages on the respiratory epithelial surface (RES); these cells release toxic oxidants, which contribute to the marked epithelial derangements seen in CF. These deleterious consequences are magnified, since reduced glutathione (GSH), an antioxidant present in high concentrations in normal respiratory epithelial lining fluid (ELF), is deficient in CF ELF. To evaluate the feasibility of increasing ELF GSH levels and enhancing RES antioxidant protection, GSH aerosol was delivered (600 mg twice daily for 3 days) to seven patients with CF. ELF total, reduced, and oxidized GSH increased (P < 0.05, all compared with before GSH therapy), suggesting adequate RES delivery and utilization of GSH. Phorbol 12-myristate 13-acetate-stimulated superoxide anion (O-2·) release by ELF inflammatory cells decreased after GSH therapy (P < 0.002). This paralleled observations that GSH added in vitro to CF ELF inflammatory cells suppressed O-2· release (P < 0.001). No adverse effects were noted during treatment. Together, these observations demonstrate the feasibility of using GSH aerosol to restore RES oxidant-antioxidant balance in CF and support the rationale for further clinical evaluation.

antioxidant; bronchoalveolar lavage; neutrophil; respiratory epithelium; superoxide anion


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
J. Prousky
The Treatment of Pulmonary Diseases and Respiratory-Related Conditions with Inhaled (Nebulized or Aerosolized) Glutathione
Evid. Based Complement. Altern. Med., March 1, 2008; 5(1): 27 - 35.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. D. Sagel, J. F. Chmiel, and M. W. Konstan
Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease
Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Kariya, H. Leitner, E. Min, C. van Heeckeren, A. van Heeckeren, and B. J. Day
A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1590 - L1597.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. P. Carroll, C. M. Greene, C. C. Taggart, A. G. Bowie, S. J. O'Neill, and N. G. McElvaney
Viral Inhibition of IL-1- and Neutrophil Elastase-Induced Inflammatory Responses in Bronchial Epithelial Cells
J. Immunol., December 1, 2005; 175(11): 7594 - 7601.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
O. Ciofu, B. Riis, T. Pressler, H. E. Poulsen, and N. Hoiby
Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation
Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2276 - 2282.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
B. J. Day
Glutathione: A Radical Treatment for Cystic Fibrosis Lung Disease?
Chest, January 1, 2005; 127(1): 12 - 14.
[Full Text] [PDF]

Home page
 ChestHome page
C. Bishop, V. M. Hudson, S. C. Hilton, and C. Wilde
A Pilot Study of the Effect of Inhaled Buffered Reduced Glutathione on the Clinical Status of Patients With Cystic Fibrosis
Chest, January 1, 2005; 127(1): 308 - 317.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
D. R. Koehler, G. P. Downey, N. B. Sweezey, A. K. Tanswell, and J. Hu
Lung Inflammation as a Therapeutic Target in Cystic Fibrosis
Am. J. Respir. Cell Mol. Biol., October 1, 2004; 31(4): 377 - 381.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Q. O'Malley, K. J. Reszka, D. R. Spitz, G. M. Denning, and B. E. Britigan
Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L94 - L103.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Griese, J. Ramakers, A. Krasselt, V. Starosta, S. van Koningsbruggen, R. Fischer, F. Ratjen, B. Mullinger, R. M. Huber, K. Maier, et al.
Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 822 - 828.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
C. J. Venglarik, J. Giron-Calle, A. F. Wigley, E. Malle, N. Watanabe, and H. J. Forman
Hypochlorous acid alters bronchial epithelial cell membrane properties and prevention by extracellular glutathione
J Appl Physiol, December 1, 2003; 95(6): 2444 - 2452.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. L. Gibson, J. L. Burns, and B. W. Ramsey
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Kantengwa, L. Jornot, C. Devenoges, and L. P. Nicod
Superoxide Anions Induce the Maturation of Human Dendritic Cells
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 431 - 437.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. H. Snyder, M. E. McPherson, J. F. Hunt, M. Johnson, J. S. Stamler, and B. Gaston
Acute Effects of Aerosolized S-Nitrosoglutathione in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 922 - 926.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H.-W. SHIN, C. M. ROSE-GOTTRON, R. S. SUFI, F. PEREZ, D. M. COOPER, A. F. WILSON, and S. C. GEORGE
Flow-independent Nitric Oxide Exchange Parameters in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 349 - 357.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. H. Roum, A. S. Aledia, L. A. Carungcong, K.-J. Kim, and Z. Borok
Extracellular glutathione inhibits oxygen-induced permeability changes in alveolar epithelial monolayers
J Appl Physiol, August 1, 2001; 91(2): 748 - 754.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. R. Pitt
CFTR trafficking and signaling in respiratory epithelium
Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L13 - L15.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. Gao, J. R. Broughman, T. Iwamoto, J. M. Tomich, C. J. Venglarik, and H. J. Forman
Synthetic chloride channel restores glutathione secretion in cystic fibrosis airway epithelia
Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L24 - L30.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. W. Velsor, A. van Heeckeren, and B. J. Day
Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice
Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L31 - L38.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. E. Walsh, C. M. Greene, T. P. Carroll, C. C. Taggart, P. M. Gallagher, S. J. O'Neill, and N. G. McElvaney
Interleukin-8 Up-regulation by Neutrophil Elastase Is Mediated by MyD88/IRAK/TRAF-6 in Human Bronchial Epithelium
J. Biol. Chem., September 14, 2001; 276(38): 35494 - 35499.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online